Search for dialysis centres here

Find a centre Log in to explore the world's most comprehensive database of dialysis centres for free!

Jobs in dialysis

dialysis.team.logo.small.000 Professional dialysis recruitment 

 

Dialysis industry news

Stories from the dialysis comunity across the globe.
Renal Dialysis Equipment Market to 2017- Lower Costs and Similar Efficacy ... - Manufacturing Digital (press release) PDF Print

NEW YORK, June 28, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Renal Dialysis Equipment Market to 2017- Lower Costs and Similar Efficacy Rates as Hemodialysis to Increase Adoption Rates of Peritoneal Dialysis

http://www.reportlinker.com/p0832800/Renal-Dialysis-Equipment-Market-to-2017--Lower-Costs-and-Similar-Efficacy-Rates-as-Hemodialysis-to-Increase-Adoption-Rates-of-Peritoneal-Dialysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Devices

Renal Dialysis Equipment Market to 2017- Lower Costs and Similar Efficacy Rates as Hemodialysis to Increase Adoption Rates of Peritoneal Dialysis

Summary

GBI Research's report, "Renal Dialysis Equipment Market to 2017- Lower Costs and Similar Efficacy Rates as Hemodialysis to Increase Adoption Rates of Peritoneal Dialysis" shows rapid growth in the number of End Stage Renal Disease (ESRD) patients owing to the growing prevalence of diabetes, hypertension and an increasingly large elderly population are driving the market globally. Factors such as the improving standards of living in developing economies and longer life expectancies of dialysis patients, due to improved access to healthcare services are also expected to boost the market. The report provides key data, information and analysis on the global renal dialysis equipment market, covering the market landscape, competitive landscape and market trends relating to four renal dialysis equipment market categories: dialysis accessories, continuous renal replacement therapy machines, peritoneal dialysis solutions and hemodialysis machines. Providing comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics, the report also reviews the competitive landscape and gives a detailed analysis of the pipeline products in each category. Details of important merger and acquisition deals that have taken place in the renal dialysis equipment market are also reviewed. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

- Key geographies: the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.

- Market size for four renal dialysis equipment market categories: dialysis accessories, continuous renal replacement therapy machines, peritoneal dialysis solutions and hemodialysis machines.

- Annualized market revenues data for 2003–2010, and forecasts for 2010–2017.

- Qualitative analysis of key market trends, market drivers, and restraints by each category within the renal dialysis equipment market.

- The report also covers information on the leading companies currently operating in the market, the competitive landscape, and the leading technologies.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the renal dialysis equipment market.

- Design and develop your product development, marketing and sales strategies.

- Capitalize on M&A opportunities by identifying key companies with the most innovative pipeline.

- Develop market entry and market expansion strategies.

- Identify the key companies that are best positioned to take advantage of emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.

- Identify, understand and capitalize on the next big thing in the renal dialysis equipment market landscape

- Make more informed business decisions from the insightful and in-depth analysis of the renal dialysis equipment market and the factors shaping it.

 

1 Table of Contents

1 Table of Contents 4

1.1 List of Tables 6

1.2 List of Figures 7

2 Introduction 8

2.1 GBI Research Guidance 8

3 Renal Dialysis Equipment - Overview 9

3.1 Renal Dialysis Equipment 9

3.1.1 Continuous Renal Replacement Therapy Machines 9

3.1.2 Dialysis Accessories 9

3.1.3 Hemodialysis Machines 9

3.1.4 Peritoneal Dialysis Solutions 9

4 Renal Dialysis Equipment, Global - Market Characterization 10

4.1 Renal Dialysis Equipment, Global, Revenue ($m), 2003 - 2010 10

4.2 Renal Dialysis Equipment, Global, Revenue ($m), 2010–2017 11

4.3 Renal Dialysis Equipment, Global, Company Share (%), 2010 12

4.4 Renal Dialysis Equipment, Global, Market Trends 13

4.4.1 Peritoneal Dialysis to be Preferred over Hemodialysis in the Near Future 13

4.4.2 Rising Trend of Integrating Product Manufacturers and Service Providers 13

4.4.3 Wearable Artificial Kidney – an Upcoming Technology Trend 13

4.5 Renal Dialysis Equipment, Global, Market Dynamics 14

4.5.1 Market Drivers 14

4.5.2 Market Restraints 15

5 Renal Dialysis Equipment, Global - Category Analysis and Forecasts 16

5.1 Renal Dialysis Equipment, Continuous Renal Replacement Therapy, Global 17

5.2 Renal Dialysis Equipment, Dialysis Accessories, Global 19

5.2.1 Dialysis Accessories, Market Driver 21

5.2.2 Dialysis Accessories, Market Restraint 21

5.3 Renal Dialysis Equipment, Hemodialysis, Global 22

5.3.1 Hemodialysis Machines, Market Driver 24

5.3.2 Hemodialysis Machines, Market Restraint 24

5.4 Renal Dialysis Equipment, Peritoneal Dialysis Solutions, Global 25

5.4.1 Peritoneal Dialysis Solutions, Market Driver 27

5.4.2 Peritoneal Dialysis Solutions, Market Restraints 27

6 Renal Dialysis Equipment, Global - Country Analysis and Forecasts 28

6.1 Renal Dialysis Equipment, The US, Revenue ($m), 2003–2010 29

6.2 Renal Dialysis Equipment, The US, Revenue ($m), 2010–2017 30

6.3 Renal Dialysis Equipment, Canada, Revenue ($m), 2003–2010 31

6.4 Renal Dialysis Equipment, Canada, Revenue ($m), 2010–2017 32

6.5 Renal Dialysis Equipment, The UK, Revenue ($m), 2003–2010 33

6.6 Renal Dialysis Equipment, The UK, Revenue ($m), 2010–2017 34

6.7 Renal Dialysis Equipment, Germany, Revenue ($m), 2003–2010 35

6.8 Renal Dialysis Equipment, Germany, Revenue ($m), 2010–2017 36

6.9 Renal Dialysis Equipment, France, Revenue ($m), 2003–2010 37

6.10 Renal Dialysis Equipment, France, Revenue ($m), 2010–2017 38

6.11 Renal Dialysis Equipment, Italy, Revenue ($m), 2003–2010 39

6.12 Renal Dialysis Equipment, Italy, Revenue ($m), 2010–2017 40

6.13 Renal Dialysis Equipment, Spain, Revenue ($m), 2003–2010 41

6.14 Renal Dialysis Equipment, Spain, Revenue ($m), 2010–2017 42

6.15 Renal Dialysis Equipment, Brazil, Revenue ($m), 2003–2010 43

6.16 Renal Dialysis Equipment, Brazil, Revenue ($m), 2010–2017 44

6.17 Renal Dialysis Equipment, Australia, Revenue ($m), 2003–2010 45

6.18 Renal Dialysis Equipment, Australia, Revenue ($m), 2010–2017 46

6.19 Renal Dialysis Equipment, China, Revenue ($m), 2003–2010 47

6.20 Renal Dialysis Equipment, China, Revenue ($m), 2010–2017 48

6.21 Renal Dialysis Equipment, India, Revenue ($m), 2003–2010 49

6.22 Renal Dialysis Equipment, India, Revenue ($m), 2010–2017 50

6.23 Renal Dialysis Equipment, Japan, Revenue ($m), 2003–2010 51

6.24 Renal Dialysis Equipment, Japan, Revenue ($m), 2010–2017 52

7 Renal Dialysis Equipment, Global - Future Outlook 53

7.1 Epidemiology 53

7.2 Disease Burden 53

7.3 Costs 53

7.4 Peritoneal Dialysis versus Hemodialysis 54

8 Renal Dialysis Equipment, Global - Competitive Assessment 55

8.1 Renal Dialysis Equipment Market, Opportunities and Threats 55

8.2 Renal Dialysis Equipment Market, Key Market Participants 56

8.2.1 Fresenius Medical Care AG & Co. KGaA 56

8.2.2 Baxter International Inc. 59

8.2.3 Gambro AB 60

8.2.4 Nipro Corporation 62

8.2.5 B. Braun Melsungen AG 63

9 Renal Dialysis Equipment, Global - Product Pipeline Analysis 65

9.1 Profiles of Key Products Under Clinical Development 68

9.1.1 Theralite 68

9.1.2 Automated Peritoneal Dialysis Cycler – Next Generation 68

9.1.3 Home Hemodialysis System 69

9.1.4 AK 200 Ultra S 70

9.1.5 Artis System 70

9.1.6 OLpur MD 220 70

9.1.7 Wearable Artificial Kidney 71

10 Renal Dialysis Equipment, Global - Consolidation Landscape 74

10.1 Key Deals - Mergers and Acquisitions 75

10.1.1 Fresenius Medical Care Acquires Hema Metrics Crit-Line system business 75

10.1.2 Fresenius Medical Care Acquires Peritoneal Dialysis Business from Gambro 75

10.1.3 Fresenius Medical Acquires Renal Solutions 75

10.1.4 NxStage Medical Acquires Medisystems 75

10.1.5 Gambro Acquires Hemapure 76

10.2 Key Deals – Partnerships 76

10.2.1 Fresenius Medical Care Enters into an Agreement with Nikkiso 76

10.2.2 NxStage Signs Distribution Agreement with Spindial for System One 76

10.2.3 Interface Biologics Signs Exclusive License Option Agreement with Fresenius Medical Care 77

10.2.4 Gambro Enters into an Agreement with Debiotech 77

10.3 Key Deals – Private Equity/Venture Capital 77

10.3.1 EQT and Investor AB Acquires Gambro through Indap 77

11 Appendix 78

11.1 Definitions 78

11.1.1 Renal Dialysis Equipment 78

11.1.2 Hemodialysis Machines 78

11.1.3 Peritoneal Dialysis Solutions 78

11.1.4 Continuous Renal Replacement Therapy Machines 78

11.1.5 Dialysis Accessories 78

11.2 Acronyms 79

11.3 Sources 80

11.4 Research Methodology 81

11.4.1 Secondary Research 81

11.4.2 Primary Research 81

11.4.3 Models 82

11.4.4 Forecasts 82

11.4.5 Expert Panels 82

11.5 Contact Us 82

11.6 Disclaimer 83

 

1.1 List of Tables

Table 1: Renal Dialysis Equipment, Global, Revenue ($m), 2003-2010 10

Table 2: Renal Dialysis Equipment, Global, Revenue ($m), 2010-2017 11

Table 3: Renal Dialysis Equipment, Global, Company Revenue ($m), 2010 12

Table 4: Renal Dialysis Equipment, Continuous Renal Replacement Therapy, Global, Revenue ($m), 2003-2010 17

Table 5: Renal Dialysis Equipment, Continuous Renal Replacement Therapy, Global, Revenue ($m), 2010-2007 18

Table 6: Renal Dialysis Equipment, Dialysis Accessories, Global, Revenue ($m), 2003-2010 19

Table 7: Renal Dialysis Equipment, Dialysis Accessories, Global, Revenue ($m), 2010-2017 20

Table 8: Renal Dialysis Equipment, Hemodialysis, Global, Revenue ($m), 2003-2010 22

Table 9: Renal Dialysis Equipment, Hemodialysis, Global, Revenue ($m), 2010-2017 23

Table 10: Renal Dialysis Equipment, Peritoneal Dialysis Solutions, Global, Revenue ($m), 2003-2010 25

Table 11: Renal Dialysis Equipment, Peritoneal Dialysis Solutions, Global, Revenue ($m), 2010-2017 26

Table 12: Renal Dialysis Equipment, The US, Revenue ($m), 2003-2010 29

Table 13: Renal Dialysis Equipment, The US, Revenue ($m), 2010-2017 30

Table 14: Renal Dialysis Equipment, Canada, Revenue ($m), 2003-2010 31

Table 15: Renal Dialysis Equipment, Canada, Revenue ($m), 2010-2017 32

Table 16: Renal Dialysis Equipment, The UK, Revenue ($m), 2003-2010 33

Table 17: Renal Dialysis Equipment, The UK, Revenue ($m), 2010-2017 34

Table 18: Renal Dialysis Equipment, Germany, Revenue ($m), 2003-2010 35

Table 19: Renal Dialysis Equipment, Germany, Revenue ($m), 2010-2017 36

Table 20: Renal Dialysis Equipment, France, Revenue ($m), 2003-2010 37

Table 21: Renal Dialysis Equipment, France, Revenue ($m), 2010-2017 38

Table 22: Renal Dialysis Equipment, Italy, Revenue ($m), 2003-2010 39

Table 23: Renal Dialysis Equipment, Italy, Revenue ($m), 2010-2017 40

Table 24: Renal Dialysis Equipment, Spain, Revenue ($m), 2003-2010 41

Table 25: Renal Dialysis Equipment, Spain, Revenue ($m), 2010-2017 42

Table 26: Renal Dialysis Equipment, Brazil, Revenue ($m), 2003-2010 43

Table 27: Renal Dialysis Equipment, Brazil, Revenue ($m), 2010-2017 44

Table 28: Renal Dialysis Equipment, Australia, Revenue ($m), 2003-2010 45

Table 29: Renal Dialysis Equipment, Australia, Revenue ($m), 2010-2017 46

Table 30: Renal Dialysis Equipment, China, Revenue ($m), 2003-2010 47

Table 31: Renal Dialysis Equipment, China, Revenue ($m), 2010-2017 48

Table 32: Renal Dialysis Equipment, India, Revenue ($m), 2003-2010 49

Table 33: Renal Dialysis Equipment, India, Revenue ($m), 2010-2017 50

Table 34: Renal Dialysis Equipment, Japan, Revenue ($m), 2003-2010 51

Table 35: Renal Dialysis Equipment, Japan, Revenue ($m), 2010-2017 52

Table 36: Fresenius Medical Care AG & Co. KGaA, Key Marketed Products, 2011 57

Table 37: Baxter International Inc., Key Marketed Products, 2011 59

Table 38: Gambro AB, Key Marketed Products, 2011 61

Table 39: Nipro Corporation, Key Marketed Products, 2011 62

Table 40: B. Braun Melsungen AG, Key Marketed Products, 2011 63

Table 41: Renal Dialysis Equipment, Global, Product Pipeline Analysis 65

Table 42: Renal Dialysis Equipment, Global Pipeline Products, 2011- Table-1 66

Table 43: Renal Dialysis Equipment, Global Pipeline Products, 2011- Table-2 67

Table 44: Theralite, Product Status, 2011 68

Table 45: Automated Peritoneal Dialysis Cycler - Next Generation, Product Status, 2011 68

Table 46: Home Hemodialysis System, Product Status, 2011 69

Table 47: Home Hemodialysis System 69

Table 48: AK 200 Ultra S, Product Status, 2011 70

Table 49: Artis System, Product Status, 2011 70

Table 50: OLpur MD 220, Product Status, 2011 71

Table 51: OLpur MD 220, Clinical Trial, 2011 71

Table 52: Wearable Artificial Kidney, Product Status, 2011 72

Table 53: Wearable Artificial Kidney, Clinical Trial, 2011 73

Table 54: Renal Dialysis Equipment, Global: Consolidation Landscape 74

 

1.2 List of Figures

Figure 1: Renal Dialysis Equipment, Global, Revenue ($m), 2003–2010 10

Figure 2: Renal Dialysis Equipment, Global, Revenue ($m), 2010–2017 11

Figure 3: Renal Dialysis Equipment, Global, Company Share (%), 2010 12

Figure 4: Renal Dialysis Equipment, Global, Category Analysis and Forecasts 16

Figure 5: Renal Dialysis Equipment, Continuous Renal Replacement Therapy, Global, Revenue ($m), 2003–2010 17

Figure 6: Renal Dialysis Equipment, Continuous Renal Replacement Therapy, Global, Revenue ($m), 2010–2007 18

Figure 7: Renal Dialysis Equipment, Dialysis Accessories, Global, Revenue ($m), 2003–2010 19

Figure 8: Renal Dialysis Equipment, Dialysis Accessories, Global, Revenue ($m), 2010–2017 20

Figure 9: Renal Dialysis Equipment, Hemodialysis, Global, Revenue ($m), 2003–2010 22

Figure 10: Renal Dialysis Equipment, Hemodialysis, Global, Revenue ($m), 2010–2017 23

Figure 11: Renal Dialysis Equipment, Peritoneal Dialysis Solutions, Global, Revenue ($m), 2003–2010 25

Figure 12: Renal Dialysis Equipment, Peritoneal Dialysis Solutions, Global, Revenue ($m), 2010–2017 26

Figure 13: Renal Dialysis Equipment, Global, Country Analysis and Forecasts, 2003–2017 28

Figure 14: Renal Dialysis Equipment, The US, Revenue ($m), 2003–2010 29

Figure 15: Renal Dialysis Equipment, The US, Revenue ($m), 2010–2017 30

Figure 16: Renal Dialysis Equipment, Canada, Revenue ($m), 2003–2010 31

Figure 17: Renal Dialysis Equipment, Canada, Revenue ($m), 2010–2017 32

Figure 18: Renal Dialysis Equipment, The UK, Revenue ($m), 2003–2010 33

Figure 19: Renal Dialysis Equipment, The UK, Revenue ($m), 2010–2017 34

Figure 20: Renal Dialysis Equipment, Germany, Revenue ($m), 2003–2010 35

Figure 21: Renal Dialysis Equipment, Germany, Revenue ($m), 2010–2017 36

Figure 22: Renal Dialysis Equipment, France, Revenue ($m), 2003–2010 37

Figure 23: Renal Dialysis Equipment, France, Revenue ($m), 2010–2017 38

Figure 24: Renal Dialysis Equipment, Italy, Revenue ($m), 2003–2010 39

Figure 25: Renal Dialysis Equipment, Italy, Revenue ($m), 2010–2017 40

Figure 26: Renal Dialysis Equipment, Spain, Revenue ($m), 2003–2010 41

Figure 27: Renal Dialysis Equipment, Spain, Revenue ($m), 2010–2017 42

Figure 28: Renal Dialysis Equipment, Brazil, Revenue ($m), 2003–2010 43

Figure 29: Renal Dialysis Equipment, Brazil, Revenue ($m), 2010–2017 44

Figure 30: Renal Dialysis Equipment, Australia, Revenue ($m), 2003–2010 45

Figure 31: Renal Dialysis Equipment, Australia, Revenue ($m), 2010–2017 46

Figure 32: Renal Dialysis Equipment, China, Revenue ($m), 2003–2010 47

Figure 33: Renal Dialysis Equipment, China, Revenue ($m), 2010–2017 48

Figure 34: Renal Dialysis Equipment, India, Revenue ($m), 2003–2010 49

Figure 35: Renal Dialysis Equipment, India, Revenue ($m), 2010–2017 50

Figure 36: Renal Dialysis Equipment, Japan, Revenue ($m), 2003–2010 51

Figure 37: Renal Dialysis Equipment, Japan, Revenue ($m), 2010–2017 52

Figure 38: Renal Dialysis Equipment, Global, Company Share (%), 2010 55

Figure 39: Renal Dialysis Equipment, Global, Product Pipeline Analysis 65

Figure 40: Renal Dialysis Equipment, Global: Consolidation Landscape 2007–2011* 74

 

Companies mentioned

Fresenius Medical Care AG & Co. KGaA
Baxter International Inc.
Gambro AB
Nipro Corporation
B. Braun Melsungen AG

To order this report:Medical Devices Industry:Renal Dialysis Equipment Market to 2017- Lower Costs and Similar Efficacy Rates as Hemodialysis to Increase Adoption Rates of Peritoneal Dialysis

More Market Research Report

Check our Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

...
 
Council support for St John dialysis centre - Selangor Times PDF Print
Selangor Times
The fully-equipped dialysis centre, which had been set up in an MPSJ hall, had been in limbo for nearly a year for not meeting new regulations under the Private Health Care Facilities and Services Act 2008. “We understand that the machines are already

...
 
FDA Declares Fresenius Medical Care Warning for GranuFlo, NaturaLyte ... - San Francisco Chronicle (press release) PDF Print

Parker Waichman is now advising that the FDA has issued a Class I Recall for GranuFlo and NaturaLyte Dialysis Products manufactured by Fresenius Medical Care. This FDA Action Follows Revelation that Over 900 Patients Suffered Cardiac Arrest at Fresenius Dialysis Clinics in 2010. According to the company, GranuFlo and NaturaLyte are Associated with Elevated Bicarbonate Levels, a Significant Risk Factor for Cardiac Arrest.

New York, New York (PRWEB) June 28, 2012

Parker Waichman LLP, a national law firm dedicated to protecting the legal rights of people injured by defective medical devices, reports that the U.S. Food & Drug Administration (FDA) has declared Fresenius Medical Care's recent warning regarding its GranuFlo and NaturaLyte dialysis products to be a Class I recall, the agency's most serious medical device recall category. In March 2012, Fresenius issued an Urgent Product Notification warning its customers that GranuFlo and NaturaLyte are associated with elevated bicarbonate levels, a significant risk factor for cardiac arrest. Parker Waichman LLP first reported on these issues in a press release issued by the firm on June 21, 2012.

According to the FDA, Class I recalls are the most serious type of recall and involve situations in which there is a reasonable probability that use of a product will cause serious adverse health consequences or death.

GranuFlo and NaturaLyte are alkaline substance administered to dialysis patients to neutralize the acid that builds up in the blood. The products are administered in conjunction with bicarbonate, and contain acetate, an ingredient that the body converts to bicarbonate. However, GranuFlo and NaturaLyte contain far more acetate than rival products, and thus result in more bicarbonate in the body.

According to the Times, Fresenius is being investigated for failing to warn its customers about the serious risks associated with GranuFlo and NaturaLyte. According to the report, Fresenius had issued an internal memo to its own clinics on November 4, 2011, warning that 941 hemodialysis patients experienced cardiac arrest at 667 Fresenius facilities in 2010. The company conducted an analysis of these patients, comparing them to over 80,000 other dialysis patients in the same centers. Overall, the data indicated that excess bicarbonate, or alkalosis, significantly increased the risk of heart problems in hemodialysis patients.

While Fresenius alerted its own physicians and medical directors about the issue, it did not notify the public or the FDA about the findings until the agency received an anonymous copy of the memo and inquired about it. In May, the FDA issued a Safety Communication warning about alkali dosing errors for products like GranuFlo and NaturaLyte in hemodialysis patients. “Given that Fresenius’ actions or inaction raise concerns as to whether Fresenius is capable of appropriately advising facilities using GranuFlo and NaturaLyte Dialysis Products of their inherent danger, FDA’s Class I recall is a welcomed action,” says Matthew McCauley, Senior Litigation Counsel at Parker Waichman LLP. He also stated that, “by taking this action, FDA essentially ordered Fresenius to take the necessary steps to advise ALL, not just Fresenius owned, facilities using GranuFlo and NaturaLyte Dialysis Products that these products are being investigated for serious safety concerns.”

Parker Waichman LLP offers free lawsuit consultations to victims of Fresenius GranuFlo and NaturaLyte side effects. If you or a loved one experienced sudden cardiac arrest or sudden heart attack following dialysis with GranuFlo or NaturaLyte, please visit the firm's GranuFlo and NaturaLyte injury page at yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

For more information regarding Fresenius GranuFlo and NaturaLyte lawsuits and Parker Waichman LLP, please visit: yourlawyer.com or call 1-800-LAW-INFO (1-800-529-4636).
Contact:
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
(800) LAW-INFO
(800) 529-4636

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebfreseniusdialysis/62012/prweb9652817.htm

...
 
Research and Markets: North America Nephrology and Urology Devices Market ... - Business Wire (press release) PDF Print

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/bf2fsg/north_america_neph) has announced the addition of GlobalData's new report "North America Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters" to their offering.

“North America Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters”

This new report provides key market data on the North America Nephrology and Urology Devices market - Canada and United States. The report provides value (USD million) data for all the market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Countries covered include Canada and United States.

- Market size and company share data for Nephrology and Urology Devices market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment.

- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the market categories and countries.

- Global corporate-level profiles of key companies operating within the North America Nephrology and Urology Devices market..

- Key players covered include Fresenius Medical Care AG & Co. KGaA, Kimberly-Clark Corporation, Baxter International Inc., Svenska Cellulosa Aktiebolaget SCA, Gambro AB, First Quality Enterprises, Inc. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the North America Nephrology and Urology Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned

- Fresenius Medical Care AG & Co. KGaA

- Kimberly-Clark Corporation

- Baxter International Inc.

- Svenska Cellulosa Aktiebolaget SCA

- Gambro AB

- B. Braun Melsungen AG

- Covidien plc

- First Quality Enterprises, Inc.

- C. R. Bard, Inc.

- NxStage Medical, Inc.

- HARTMANN GROUP

- NIPRO CORPORATION

- Coloplast AS

- Teleflex Incorporated

- Unicharm Corporation

- Medline Industries, Inc.

- Astra Tech Inc.

- Bellco Srl

- Asahi Kasei Corporation

- Dornier MedTech GmbH

- STORZ MEDICAL AG

- Siemens Healthcare

- HealthTronics, Inc.

- EDAP TMS S.A.

For more information visit http://www.researchandmarkets.com/research/bf2fsg/north_america_neph

Source: GlobalData

...
 
Renal patient frustration at meeting - The Young Witness PDF Print
FRUSTRATIONs around renal services in the Young district have emerged this week as the result of a meeting at the Young Community Health Centre on Tuesday.

The renal service consultation, arranged by Murrumidgee Local Health District, was the final of a group of meetings held in six locations around the region to develop a new Renal Services Plan.

The meeting was attended by renal patients, their carers, clinicians, voluntary drivers, relatives of prior patients and other interested parties, along with practitioners from the health service. There was also one person from Temora who attended via video link.

The Chief Executive of the Murrumidgee Local Health District, Susan Weisser, said it was important to consult with users of the service to identify local priorities and new ways of providing care.

“We want to gather information which will enable us to make recommendations for delivering a coordinated and integrated service for those living with kidney disease,” she said.

However, the meeting was contentious due to the demand for a “full blown” renal service at the hospital.

Currently local renal patients must make the arduous journey to Canberra three times a week for nurse administered dialysis.

A self-managed unit opened in Young last year, however it is only utilised by one person.

An attendee at the meeting was Young Community Transport manager Kelly Rolfe, who coordinates a group of voluntary drivers who take renal patients to the Canberra Hospital.

Of the patients who have to travel she said, “they spend three days a week travelling and the other days getting over it.”

Ms Rolfe said she would ultimately want to see a full blown dialysis unit in Young, however, didn’t feel positive after the meeting that it would eventuate, as they went through the whole process a few years ago and not much happened.

“There’s a lot of talk, but it doesn’t seem to be happening,” she said.

She said the patients who attended the meeting were also frustrated.

...
 
More Articles...
<< Start < Prev 511 512 513 514 515 516 517 518 519 520 Next > End >>

Page 511 of 4210
Share |

Dialysis travel

Dialysis information

Global Dialysis

Copyright © 2025 Global Dialysis. All Rights Reserved.